The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS(©) )

J Peripher Nerv Syst. 2015 Sep;20(3):319-27. doi: 10.1111/jns.12120.

Abstract

Familial amyloid polyneuropathy (FAP) is a chronic debilitating multi-organic disorder, mainly assessed using ordinal-based impairment measures. To date, no outcome measure at the activity and participation level has been constructed in FAP. The current study aimed to design an interval activity/participation scale for FAP through Rasch methodology. A preliminary FAP Rasch-built overall disability scale (pre-FAP-RODS) containing 146 activity/participation items was assessed twice (interval: 2-4 week; test-retest reliability) in 248 patients with Val30Met FAP examined in Porto, Portugal, of which 65.7% have received liver transplantation. An ordinal-based 24-item FAP-symptoms inventory questionnaire (FAP-SIQ) was also assessed (validity purposes). The pre-FAP-RODS and FAP-SIQ data were subjected to Rasch analyses. The pre-FAP-RODS did not meet model's expectations. On the basis of requirements such as misfit statistics, differential item functioning, and local dependency, items were systematically removed until a final 34-item FAP-RODS(©) was constructed fulfilling all Rasch requirements. Acceptable reliability/validity scores were demonstrated. In conclusion, the 34-item FAP-RODS(©) is a disease-specific interval measure suitable for detecting activity and participation restrictions in patients with FAP. The use of the FAP-RODS(©) is recommended for future international clinical trials in patients with Val30Met FAP determining its responsiveness and its cross-cultural validation. Its expansion to other forms of FAP should also be focus of future clinical studies.

Keywords: Rasch-built disability scale; activity and participation; familial amyloid polyneuropathy; outcome research; validity and reliability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activities of Daily Living
  • Adult
  • Aged
  • Amyloid Neuropathies, Familial / genetics*
  • Amyloid Neuropathies, Familial / physiopathology*
  • Disability Evaluation*
  • Female
  • Humans
  • Male
  • Methionine / genetics
  • Middle Aged
  • Mutation / genetics*
  • Outcome Assessment, Health Care*
  • Portugal
  • Prealbumin / genetics*
  • Reproducibility of Results
  • Retrospective Studies
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Valine / genetics

Substances

  • Prealbumin
  • Methionine
  • Valine